Immune-Mediated Thrombotic Thrombocytopenic Purpura

People with immune-mediated thrombotic thrombocytopenic purpura are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least 18 to 80 years of age
• Are clinically diagnosed with thrombocytopenic purpura (iTTP)

You may not participate in this study if you:

• Have Platelet count ≥100 × 109/L
• Have congenital TTP (known at the time of study entry)
• Have inherited or acquired coagulation disorders
• Have malignant arterial hypertension
• Have severe neurological (ie, coma, seizures) or severe cardiac disease
• Have known chronic treatment with anticoagulants and anti-platelet drugs that cannot be stopped
• Have positive result on the Screening SARS-CoV-2, RT-PCR test
• Are pregnant, or breast-feeding, or planning to become pregnant

Contact Information
Noelle Townsend, Study Coordinator
Phone: 718-920-4321